Clinical Trial Update: Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating letrozole with or without simvastatin for Stage I-III hormone receptor-positive, HER2-negative breast cancer. The study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)
• Zocor (simvastatin)

Snippet

Sponsor: Emory University | Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | EARLY_Phase 1 | Status: RECRUITING